SYNNOVATION THERAPEUTICS, INC. — Form D/A
SYNNOVATION THERAPEUTICS, INC. of WILMINGTON, DE, a company, filed a Form D amendment with the SEC on 2023-12-21. The offering totals $102.5M, of which $15.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-12-21
- Form: D/A
- Accession: 0001889137-23-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $102.5M
- Amount sold: $15.0M
- Remaining: $87.5M
- Investors: 7
- Date of first sale: 2023-12-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-499739
Issuer
- Name: SYNNOVATION THERAPEUTICS, INC.
- CIK: 0001889137
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 200 POWDER MILL ROAD, WILMINGTON, DE, 19803
- Phone: 302-521-9490
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Ting Feng | Director | Wilmington, DE |
| Reid Huber | Director | Boston, MA |
| Liangxing Wu | Director | Wilmington, DE |
| Wenqing Yao | Director | Wilmington, DE |
| Liangxing Wu | Executive Officer | Wilmington, DE |
| Wenqing Yao | Executive Officer | Wilmington, DE |
Other filings by this issuer (3)
More